Loading...
Loading...
Disease surveillance, vaccination data, epidemiology, health system capacity, mortality statistics
2,858 datasets
A 2026 figshare document by Laura Gómez-Bermeo evaluates the pilot of the Epi Training Kit (EpiTKit), a Spanish-language MOOC for epidemiology and data science. The document reports results from 223 participants across 14 Latin American and Caribbean countries, detailing course completion rates, satisfaction scores, and qualitative feedback. It analyzes barriers and successes of an inclusive, gender-aware online training program.
A global satellite-based analysis linking built environment characteristics to subnational drowning mortality from 2006 to 2021. The dataset covers 203 regions across 12 countries and was created by Ryan Essex. It reveals that built environment associations with drowning risk are complex, non-linear, and shaped by development context.
China's HIV/AIDS burden among adults aged 15–49 years from 1990 to 2023, based on Global Burden of Disease Study 2023 data. The dataset includes age-standardised incidence, prevalence, mortality, and DALY rates, with ARIMA model projections to 2035. Author Huibo Yan published the data on figshare in May 2026.
An umbrella review synthesizing 14 systematic reviews and meta-analyses on influenza vaccination effectiveness and safety in populations at high risk of cardiovascular and respiratory complications. The evidence base covers more than 230 million participants, with findings assessed for methodological quality and certainty. The document was authored by Chengyan Jin and uploaded to figshare in May 2026.
An umbrella review synthesizing evidence from 14 systematic reviews and meta-analyses published up to December 1, 2025, covering over 230 million participants. The review, authored by Chengyan Jin, critically evaluates the effectiveness and safety of influenza vaccination in high-risk populations for cardiovascular and respiratory complications. It was last updated on May 26, 2026, and is available as a 19.9 KB DOCX file.
An umbrella review synthesizing evidence from 14 systematic reviews and meta-analyses on influenza vaccination for high-risk populations. The evidence base covers more than 230 million participants, with data gathered from PubMed, Embase, and the Cochrane Library up to December 1, 2025. The review was authored by Chengyan Jin and published on figshare in 2026.
Fourteen systematic reviews and meta-analyses covering over 230 million participants were synthesized in this umbrella review. The review, authored by Chengyan Jin and last updated in May 2026, critically evaluates evidence on influenza vaccination effectiveness and safety in high-risk populations. It assesses outcomes including major cardiovascular events, mortality, and COPD exacerbations.
800 survey responses from practicing nurses in Poland collected via a national cross-sectional computer-assisted web interviewing survey in late 2025. The dataset was used to validate the Polish adaptation of the Digital Competence Questionnaire for Nurses and examine correlates of perceived digital competence. The data was analyzed using factor analysis and multiple linear regression.
Archived records covering Maryland's COVID-19 pandemic from March 2020 through October 2025. The dataset aggregates cases, tests, positivity rates, hospitalizations, and confirmed and probable deaths across multiple demographic and geographic dimensions. It is provided by the State of Maryland via the Socrata platform and was last updated in May 2026.
127 chemical exposure incidents were identified from 1,270 total foodborne illness incidents evaluated by the FDA's CORE Network between 2011 and 2025. The data, authored by Brett Weed and published on figshare in 2026, details outbreaks attributed to seafood toxins, illicit drugs, toxic elements, and botanical toxins. It includes case studies illustrating distinct contamination root causes and the complexities of investigating chemical foodborne incidents.
122,133 UK Biobank participants aged 39-71 were followed from 2006-2010 until 2022 to study biological age acceleration. The data includes 24,281 incident cardiovascular disease cases and 3,614 premature deaths, with hazard ratios calculated for different biological age acceleration quartiles. This dataset, authored by Yingying Yang and shared under CC-BY-4.0, supports analysis of sex differences in ageing-related health risks.
1,131 individuals who experienced a malaria episode between January 2019 and May 2022 were surveyed across nine municipalities in five states of the Brazilian Amazon. The total economic burden of malaria in the Amazon in 2019 was approximately US$181.9 million PPP-USD. This dataset, authored by Monica Viegas Andrade and shared on figshare, provides a detailed estimate of direct, indirect, and HRQoL costs.
GBD 2021 data provides estimates for four major leukemia subtypes in China from 1990 to 2021. The dataset includes 105,670 estimated new cases in 2021 and tracks incidence, deaths, and disability-adjusted life years (DALYs) for acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Author Yudi Shangguan published this analysis on figshare under a CC-BY-4.0 license.
105,670 new leukemia cases were estimated in China in 2021. This dataset analyzes trends for four major leukemia subtypes from 1990 to 2021 using Global Burden of Disease 2021 data, with projections to 2046. It was authored by Yudi Shangguan and last updated in June 2026.
105,670 new leukemia cases were estimated in China in 2021. This dataset, authored by Yudi Shangguan and published on figshare in 2026, analyzes trends for four leukemia subtypes from 1990 to 2021 using Global Burden of Disease data. It includes projections for incidence rates up to 2046.
A study analyzing the burden of four major leukemia subtypes in China from 1990 to 2021 using Global Burden of Disease data. It includes an estimated 105,670 new leukemia cases in 2021 and projects incidence rates through 2046. The analysis was conducted by Yudi Shangguan and published on figshare in 2026.
GBD 2021 data provides estimates for the burden of four leukemia subtypes in China from 1990 to 2021. The analysis includes 105,670 estimated new cases in 2021 and uses Joinpoint regression and age-period-cohort modeling to assess trends and project future incidence. Author Yudi Shangguan published the findings on figshare under a CC-BY-4.0 license.
105,670 new leukemia cases were estimated in China in 2021. This dataset contains results from an analysis of four major leukemia subtypes—acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL)—from 1990 to 2021, using data from the Global Burden of Disease 2021 study. It was authored by Yudi Shangguan and uploaded to figshare in June 2026.
China's leukemia burden from 1990 to 2021 is analyzed for four major subtypes: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). The dataset, authored by Yudi Shangguan and shared in 2026, uses Global Burden of Disease 2021 data to assess incidence, deaths, and disability-adjusted life years (DALYs), stratified by age and sex.
105,670 new leukemia cases were estimated in China in 2021. This dataset contains long-term epidemiological trends for four major leukemia subtypes from 1990 to 2021, derived from the Global Burden of Disease 2021 database. It was authored by Yudi Shangguan and uploaded to figshare in June 2026.